Delivery Order SPE2DB24D9314-SPE2DB25FKRLG

Award Date 4/18/25
Potential Completion Date 5/9/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $5,508.60, is for the delivery of 4,567,998,778 units of Botox 200 unit vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Botox 100 unit vials and has a ceiling value of $1,850.28. The delivery order was issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 200-unit vials of the pharmaceutical Botox, with a ceiling value of $47,674.50 and a completion date of September 22, 2021. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $48,455.40, is for the delivery of 4,565,988,703 vials of Botox 100 unit injections. The period of performance runs through October 21, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,922.20, is for the delivery of 4,565,482,216 vials of Botox 100 unit. The contract has an ultimate completion date of September 5, 2024. This delivery order is placed under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,688.80, is for the delivery of Botox 100 unit vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,074.00, is to provide 100-unit vials of the drug Botox. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,614.80, is for the delivery of 4,565,109,356 vials of Botox 100 unit. The contract is not set aside and is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of 200-unit vials of BOTOX, with a ceiling value of $7,762.20 and an ultimate completion date of July 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,342.50 contract is for the delivery of 200-unit vials of Botox, a prescription drug used for medical purposes. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
  • SPE2DB24D9314
    Indefinite Delivery Contract
  • SPE2DB24D9314-SPE2DB25FKRLG
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,836.20, is for the delivery of 4,568,012,840 vials of BOTOX 200 units. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation and is valid through May 9, 2025.

Generated 7/18/25, 9:48 AM